(Q73318384)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618473%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Striatal dopamine depletion and behavioural sensitization induced by methamphetamine and 3-nitropropionic acid (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618473%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Eradiri OL

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618473%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Starr MS

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618473%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 December 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618473%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618473%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

386

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618473%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618473%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

217-226

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618473%20AND%20SRC:MED&resulttype=core&format=json

Tolerance to the neurotoxic effect of methamphetamine in rats behaviorally sensitized to methamphetamine or amphetamine.

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Glial cell line-derived neurotrophic factor attenuates the locomotor hypofunction and striatonigral neurochemical deficits induced by chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Systemic 3-nitropropionic acid: behavioral deficits and striatal damage in adult rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Parenterally administered 3-nitropropionic acid and amphetamine can combine to produce damage to terminals and cell bodies in the striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Influence of methamphetamine and neuroleptic drugs on tyrosine hydroxylase activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Apomorphine-induced biphasic circling behaviour in 6-hydroxydopamine-lesioned rats. A pharmacological kindling phenomenon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Effects of 3-nitropropionic acid on synaptosomal energy and transmitter metabolism: relevance to neurodegenerative brain diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Activity of two new potent dopaminergic agonists at the striatal and anterior pituitary levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Striatal L-dopa decarboxylase activity in Parkinson's disease in vivo: implications for the regulation of dopamine synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Basal ganglia degeneration, myelin alterations, and enzyme inhibition induced in mice by the plant toxin 3-nitropropanoic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

3-Nitropropionic acid exacerbates N-methyl-D-aspartate toxicity in striatal culture by multiple mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Selective inhibition of the tricarboxylic acid cycle of GABAergic neurons with 3-nitropropionic acid in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Stress-induced dopamine release in the neostriatum: evaluation of the role of action potentials in nigrostriatal dopamine neurons or local initiation by endogenous excitatory amino acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Systemic 3-nitropropionic acid: long-term effects on locomotor behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Parkinson's Disease: Activity of L-Dopa Decarboxylase in Discrete Brain Regions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

A selective toxicity toward cultured mesencephalic dopaminergic neurons is induced by the synergistic effects of energetic metabolism impairment and NMDA receptor activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Effects of alpha-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Time course of apomorphine-induced circling behaviour after striatal dopamine receptor denervation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

The role of glutamate in behavioral and neurotoxic effects of methamphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

The role of excitatory amino acids in experimental models of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Differential responses of extracellular GABA to intrastriatal perfusions of 3-nitropropionic acid and quinolinic acid in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Inhibition of energy metabolism by 3-nitropropionic acid activates ATP-sensitive potassium channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

The central effects of a novel dopamine agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Activities of 3,4-dihydroxy-L-phenylalanine and 5-hydroxy-L-tryptophan decarboxylases in rat brain: assay characteristics and distribution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Nigrostriatal dopamine actions on the D2 receptors mediate methamphetamine effects on the striatonigral substance P system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Inhibition of striatal energy metabolism produces cell loss in the ipsilateral substantia nigra.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Comparison of the effects of NMDA and AMPA antagonists on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine-treated mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Methamphetamines pretreatment and the vulnerability of the striatum to methamphetamine neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Differential vulnerability of dopamine receptors in the mouse brain treated with MPTP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Metabolic alterations produced by 3-nitropropionic acid in rat striata and cultured astrocytes: quantitative in vitro 1H nuclear magnetic resonance spectroscopy and biochemical characterization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Glutamatergic control over brain dopamine release in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

3‐Nitropropionic Acid Toxicity in the Striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

NMDA receptor involvement in toxicity to dopamine neurons in vitro caused by the succinate dehydrogenase inhibitor 3-nitropropionic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

In vivo vulnerability of dopamine neurons to inhibition of energy metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

Rapid ATP loss caused by methamphetamine in the mouse striatum: relationship between energy impairment and dopaminergic neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900776-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(99)00776-1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618473%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference